• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

PharmaNet Development Group Clinical Research Experts to Present at Global Professional Meetings in June

Posted on: Wednesday, 10 June 2009, 11:51 CDT

PRINCETON, N.J., June 10 /PRNewswire/ -- PharmaNet Development Group, Inc., a leading provider of clinical development services to innovative pharmaceutical, biotechnology, generic drug and medical device companies, today announced its participation at several international professional meetings during the month of June.

June 23 45th Drug Information Association (DIA) Annual Meeting San Diego, California, Booth 321 Betty Kuhnert, PhD, MBA, Executive Director, Training Services, will chair a session entitled Critical Success Strategies for Professional Development and will present "So You Have a New Job, Now What? Tactics for Surviving a Job Transition." June 24 Phacilitate's Active Immunotherapeutics Forum Barcelona, Spain Joyce Frey-Vasconcells, PhD, Executive Director, PharmaNet Consulting, will make a presentation on "Delivering Strategic Solutions to Manufacturing and Product Characterization Challenges with Allogeneic Therapies." AAPS National Biotechnology Conference Seattle, Washington, Booth 305 Taylor Technology's Robert Dodge, PhD, Laboratory Director, Immunochemistry and Cell Biology, Jason Morse, Director, Information Technology and Lisa Werdal, Database Systems Manager, will be presenting their poster: "Development and Implementation of an Information Management System for Tiered Immunogenicity Sample Testing and Reporting." Robert Dodge, PhD, Marisa Castellana, Research Scientist and Dania Yaskanin, Associate Director, Immunochemistry, will also present their poster entitled "Optimization of Commercial ELISA Kits for the Quantitation of Human Luteinizing Hormone and Follicle Stimulating Hormone." June 30 4th Annual Biopharm Asia Conference Singapore Duu-Gong Wu, PhD, Executive Director, PharmaNet Consulting, will make a presentation entitled "Overview of Follow-on Biologics Regulatory and Scientific Issues in US." He will also lead a post conference workshop on July 1 on the topic of the FDA's approval process for biologics and biological products. 49th Annual Meeting of the Teratology Society Rio Grande, Puerto Rico Bengt Danielsson, MD, PhD, Vice President, PharmaNet Consulting, will present "Exaggerated Pharmacology Versus True Toxicity." Dr. Danielsson's presentation is part of the International Life Sciences Institute and the Health and Environmental Sciences Institute's (ILSI/HESI) symposium on Maternal Toxicity and its Impact on Study Design and Data Interpretation.

About PharmaNet Development Group, Inc.

PharmaNet Development Group, Inc., a global drug development services company, provides a comprehensive range of services to the pharmaceutical, biotechnology, generic drug and medical device industries. The Company offers early and late stage consulting, Phase I clinical studies and bioanalytical analyses, and Phase II, III and IV clinical development programs. With approximately 2,400 employees and 40 facilities throughout the world, PharmaNet is a recognized leader in outsourced clinical development. For more information, please visit our website at www.pharmanet.com.

Contact: Anne-Marie Hess Phone: (609) 951-6842 E-mail: ahess@pharmanet.com

SOURCE PharmaNet Development Group, Inc.

Source: PR Newswire

More News in this Category